Hologic faces backlash over breast cancer biopsy needle shortage

Jun 17, 2026, 2:00 AM10

(Update: Jun 17, 2026, 2:00 AM)

Hologic

medical technology company

science

innovative

informative

Hologic faces backlash over breast cancer biopsy needle shortage

Hologic initiated a recall of biopsy needles in January 2026 due to safety concerns.
The FDA has warned that the shortage of these needles will last until March 2027.
The ongoing shortage poses significant challenges for breast imaging practices and patient care.

Hologic

medical technology company

Insights

News 1

Related reports

Opinions

Story

“

global policy market policy geopolitical global insight insight policy geopolitical strategic policy market trends trends market geopolitical data market shift market economic market policy impact data market insight geopolitical market data trends economic economic strategic geopolitical data trends impact shift impact analysis policy data analysis global analysis trends strategic analysis shift data data strategic economic analysis strategic shift insight global economic analysis impact geopolitical data data insight global geopolitical economic insight policy economic strategic economic data data market insight global...